GetTopicDetailResponse(id=7b8ae57644, topicName=FOLFOXIRI, introduction=FOLFOXIRI, content=null, image=null, comments=1, allHits=1855, url=https://h5.medsci.cn/topic?id=7576, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=54724, tagList=[TagDto(tagId=54724, tagName=FOLFOXIRI)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=897968, encodeId=54d389e968b4, content=<a href='/topic/show?id=7b8ae57644' target=_blank style='color:#2F92EE;'>#FOLFOXIRI#</a>和<a href='/topic/show?id=aeef922031b' target=_blank style='color:#2F92EE;'>#貝伐單抗#</a>治療轉(zhuǎn)移性<a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#結(jié)直腸癌#</a>，貝伐越來(lái)越變成萬(wàn)金油！, objectTitle=Br J Cancer：FOLFOXIRI和貝伐單抗治療轉(zhuǎn)移性結(jié)直腸癌的臨床研究匯總分析, objectType=article, longId=202252, objectId=88af2022522e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201017/1602949991877_2467676.PNG, objectUrl=/article/show_article.do?id=88af2022522e, replyNumber=0, likeNumber=274, createdTime=2020-11-09, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88af2022522e, moduleTitle=Br J Cancer：FOLFOXIRI和貝伐單抗治療轉(zhuǎn)移性結(jié)直腸癌的臨床研究匯總分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=88af2022522e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
